Saravia Silvia Gilka Munzoz, Knebel Fabian, Schroeckh Sabrina, Ziebig Reinhard, Lun Andreas, Weimann Andreas, Haberland Annekathrin, Borges Adrian C, Schimke Ingolf
Medizinische Klinik (Kardiologie), Charité--Universitätsmedizin Berlin, Berlin, Germany.
Clin Lab. 2010;56(1-2):51-8.
As shown on the basis of highly sensitive assays, cardiac troponin release is now observed after physiological heart stress and in mild heart pathologies: both are [corrected] considered unrelated to the irreversible cardiac alteration that is typically the source of release. Transitory cardiac membrane leakage was suggested as the basis. In our view, mild inflammation may drive this type of cardiac troponin release. To verify this hypothesis, marathon runners who demonstrated post-run inflammation were used as a model to correlate cTnT release and inflammation intensity.
In 78 male marathon runners who participated in the BERLIN-MARATHON 2006, cardiac troponin T (cTnT) was monitored [corrected] at three time points (pre-race, post-race, and after two weeks of rest). [corrected] Measurements were done with the highly sensitive assay (hs cTnT assay) and the conventional fourth-generation cTnT assay for comparison. Concurrently, [corrected] the inflammation markers (leukocyte and neutrophil counts, CRP, IL-6) were measured.
Pre-race, the fourth-generation assay failed to demonstrate cTnT positivity (> test specific LLD). In contrast, with the [corrected] use of the highly sensitive assay, 28% of the participants were positive for cTnT (> LLD of hs cTnT assay). Post-race, cTnT as measured with the fourth-generation assay was observed to be detectable in 43% of the runners (> LLD = 99(th) percentile cut off), but all runners had detectable cTnT values (> LLD) when measured with the highly sensitive assay. Even in 94% of these cTnT-positive runners, the value exceeded the 99(th) percentile cut off determined for the highly sensitive assay (13 ng/L). cTnT release correlated significantly with inflammation intensity. Faster runners demonstrated significantly stronger cTnT releases and inflammation signs.
As demonstrated after physiological heart stress such as marathon running, transitory inflammation is evidently one of the events contributing to the cardiac troponin release under conditions suggested as unrelated to irreversible cardiac alteration.
基于高灵敏度检测显示,现在在生理性心脏应激后以及轻度心脏病变中可观察到心肌肌钙蛋白释放:这两种情况均[校正后]被认为与通常作为释放来源的不可逆心脏改变无关。有人提出短暂性心脏膜渗漏是其基础。我们认为,轻度炎症可能驱动这种类型的心肌肌钙蛋白释放。为验证这一假设,将赛后出现炎症的马拉松运动员作为模型,以关联肌钙蛋白T(cTnT)释放与炎症强度。
在78名参加2006年柏林马拉松赛的男性马拉松运动员中,在三个时间点(赛前、赛后以及休息两周后)[校正后]监测心肌肌钙蛋白T(cTnT)。[校正后]使用高灵敏度检测法(hs cTnT检测法)进行测量,并使用传统的第四代cTnT检测法进行比较。同时,[校正后]测量炎症标志物(白细胞和中性粒细胞计数、CRP、IL-6)。
赛前,第四代检测法未能显示cTnT阳性(>检测特异性最低检测限)。相比之下,使用[校正后]高灵敏度检测法时,28%的参与者cTnT呈阳性(>hs cTnT检测法的最低检测限)。赛后,用第四代检测法测量时,43%的跑步者可检测到cTnT(>最低检测限=第99百分位数临界值),但用高灵敏度检测法测量时,所有跑步者的cTnT值均>最低检测限。即使在这些cTnT阳性跑步者中,94%的值超过了高灵敏度检测法确定的第99百分位数临界值(13 ng/L)。cTnT释放与炎症强度显著相关。跑得更快的跑步者表现出明显更强的cTnT释放和炎症迹象。
如马拉松跑步等生理性心脏应激后所证明的,短暂性炎症显然是在被认为与不可逆心脏改变无关的情况下导致心肌肌钙蛋白释放的因素之一。